Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Sell
103,600
-64,300
-38% -$686K ﹤0.01% 2761
2026
Q1
$1.86M Buy
167,900
+49,500
+42% +$630K ﹤0.01% 2353
2025
Q4
$1.94M Buy
+118,400
New +$1.84M ﹤0.01% 2495
2025
Q3
Sell
-133,900
Closed -$1.71M 2593
2025
Q2
$1.71M Buy
+133,900
New +$1.61M ﹤0.01% 1373
2024
Q2
Sell
-66,700
Closed -$1.51M 2302
2024
Q1
$1.51M Sell
66,700
-39,400
-37% -$922K ﹤0.01% 1353
2023
Q4
$2.64M Hold
106,100
0.01% 1116
2023
Q3
$1.82M Buy
+106,100
New +$1.77M 0.01% 1160

Other funds holding PATH

Steven Cohen's PATH Position: Q2 2026 in Review

Steven Cohen reduced its UiPath (PATH) stake by 81% in Q2 2026, selling an estimated $16.8M and leaving 368,837 shares worth $4.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1913.

Steven Cohen first reported a position in PATH in Q1 2022 and has held it in 7 quarters since. The position peaked at $121M in Q4 2025. 525 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • Steven Cohen held 368,837 shares of UiPath worth $4.01M as of Q2 2026.
  • Steven Cohen sold 1,577,345 UiPath shares in Q2 2026, an estimated $16.8M.
  • UiPath made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #1913 holding.
  • Steven Cohen first reported a position in UiPath in Q1 2022 and has held it in 7 quarters since.
  • Steven Cohen's UiPath position peaked at $121M in Q4 2025.
  • 525 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.